targets is progressing was not assessed. We assessed HIV care continuum outcomes as surrogate markers for the 90-90-90 targets. Methodology: Data were collected from a 12 years retrospective ... UNAIDS diagnosis target…
attempt also made to investigate the importance of Rifampicin resistance (RMPr) as a surrogate marker for multidrug resistance (MDR) tuberculosis. Forty-three sputum (acid fast bacilli smear positive =1+ & above…
availability of surrogate markers of severity of atherosclerosis is essential to monitor and prevent cardiovascular morbidity associated with atherosclerosis. Carotid intima media thickness (c-IMT)) is a marker of…
morbidities. We aimed to investigate whether Waterlow score could be used as an independent surrogate marker to predict severity and adverse outcome in acute pancreatitis. Methods: In this retrospective analysis
control but for proteinuric patients. On the other hand the value of microalbuminuria as surrogate marker of renal disease progression is controversial in hypertensive non diabetic patients. Furthermore, frequently
readily available. The study identifies cost effective, reliable and readily available simple surrogate markers of IR. This will help in the easy detection of IR in low resource settings
after starting treatment with HU to determine if macrocytosis can be used as a surrogate marker of compliance with therapy. We conducted a prospective cohort study over one year with
identification of other markers for management of HIV. CD38 is one such candidate marker. The main the correlation between CD38 antibody binding capacity (ABC) and viral load. A a negative ... management. However, more…
with the levels of other immunoglobulins, suggesting an important role for IgE as a surrogate marker of disease progression Keywords: Reaginic antibody, Hypersensitivity, Hypergammaglobulinemia
specifi city) during HAART (Table 1). Conclusion: TLC can be used as a surrogate marker for predicting CD4 count of HIVinfected children for making decisions about the initiation and monitoring
local settings, adversely affecting the ANC, reticulocyte count may be considered as an alternative marker. Aims and objectives: To determine the correlation of reticulocyte count with bone marrow cytology after…
discuss the special histological variants with special emphasis on their molecular phenotype using surrogate immunohistochemical markers. RESULTS Special variants of breast carcinomas diagnosed during the study period…
T2DM patients with DPR. Levels of CFU-EPCs can be used as a surrogate biologic marker to determine the severity of diabetic retinopathy and for cumulative vascular risk
T2DM patients with DPR. Levels of CFU-EPCs can be used as a surrogate biologic marker to determine the severity of diabetic retinopathy and for cumulative vascular risk
fluid (CSF) in patients with a high probability for autoimmune encephalitis (hAE) to identify surrogate biomarkers indicative of neuroinflammation. Methods: Over 18 months, hAE adult patients (as determined…